A2A ADENOSINE RECEPTOR ANTAGONISTS

Details for Australian Patent Application No. 2002357295 (hide)

Owner CV THERAPEUTICS, INC.

Inventors CRISTALLI, Gloria

Pub. Number AU-A-2002357295

PCT Number PCT/US02/40361

PCT Pub. Number WO2003/051882

Priority 60/342,455 18.12.01 US

Filing date 18 December 2002

Wipo publication date 30 June 2003

International Classifications

C07D 473/16 Heterocyclic compounds containing purine ring systems

C07D 473/18 Heterocyclic compounds containing purine ring systems

C07D 473/24 Heterocyclic compounds containing purine ring systems

A61K 031/52

A61P 025/00 Drugs for disorders of the nervous system

Event Publications

27 March 2003 Complete Application Filed

  Priority application(s): 60/342,455 18.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-A-2002357295

2 September 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002357296-SCALING FACTOR TOOLS

2002357294-SEQUENTIAL DATA TRANSFER DETECTION